Cover Image
市場調查報告書

全球眼科藥物及設備市場、機會、分析、市場佔有率及預測

Global Ophthalmic Drug & Devices Market, Opportunity, Analysis, Market Shares And Forecast 2016 - 2022

出版商 Occams Business Research & Consulting Pvt. Ltd. 商品編碼 370297
出版日期 內容資訊 英文 140 Pages
商品交期: 請詢問到貨日
價格
Back to Top
全球眼科藥物及設備市場、機會、分析、市場佔有率及預測 Global Ophthalmic Drug & Devices Market, Opportunity, Analysis, Market Shares And Forecast 2016 - 2022
出版日期: 2016年09月09日 內容資訊: 英文 140 Pages
簡介

本報告提供全球眼科藥物及設備市場相關調查,市場概要和各市場區隔,各地區趨勢,競爭環境,及加入此市場的主要企業簡介等彙整資料。

第1章 簡介

第2章 市場概要

  • 市場定義和範圍
  • 主要調查結果
  • 指標分析
  • 主要的市場趨勢
  • 競爭趨勢
    • 市場佔有率分析
    • 市場策略
    • 案例研究
  • 波特五力分析模式
  • 主要的購買標準
  • 策略性建議
  • 策略性結論

第3章 市場決策因素

  • 推動市場的要素
  • 推動市場的要素
  • 市場課題
  • 市場機會
  • 親市場
  • 競爭市場
  • 替代市場

第4章 市場區隔

  • 各治療
  • 各類型
  • 各終端用戶

第5章 各地區分析

  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第6章 企業簡介

  • ABBOT LABORATORIES
  • AKORN
  • ALLERGAN INC.
  • BAYER
  • CIPLA PHARMACEUTICALS
  • EYE GATE PHARMACEUTICALS
  • EYEMED
  • GLAXOSMITHKLINE
  • JOHNSON AND JOHNSON
  • LPATH
  • MERCK & CO.
  • NOVAGALI PHARMA S.A.
  • NOVARTIS AG
  • PFIZER INC.
  • REGENERON
  • ROCHE HOLDING AG
  • 參天製藥株式會社
  • SENJU
  • SUN PHARMACEUTICALS
  • VALEANT

圖表

目錄
Product Code: HPH-2990916

Ophthalmic drugs are drugs and medicines for eye conditions and eye diseases. The ophthalmic drugs can be categorized into two broad categories, mainly prescribed drugs and over the counter (OTC) drugs. Many OTC drugs are used by the patients with various conditions pertaining to eye and eye diseases; and holds the largest market share in the ophthalmic drugs market. However, various side effects and severe consequences related to the usage of the over the counter medications is a major drawback for this segment. The market for global ophthalmic drugs market was valued around $17,290 million in the year 2015 and is projected to grow with a CAGR of around 7% during the forecast period of 2016-2022.

The global ophthalmic drugs market is set to display a stable growth during 2016-2022 period which is attributed to various influencing factors such as the mounting prevalence of eye diseases and eye related disorders such as glaucoma and cataract, along with the expanding pool of geriatric population across the globe who are more prone to age-related macular degeneration, it is characterized by loss of central vision. Also, the various pending regulatory approvals to new ophthalmic drugs that are expected to get approval by the end of the forecast period, along with the heightened sense of awareness among people, especially in the emerging economies are creating significant opportunities for the market. Moreover, rapid technological advancements and innovations resulting in combining drugs and device therapy, and various implants are being used to treat a wide array of eye related disorder. Some of these implants such as ODTx, MicroPump, transscleral and encapsulated cell therapy are expected to provide further boost to the ophthalmic drugs market. This, along with the growing healthcare expenditure by various economies across the globe are expected to propel the growth of the market. However, factors such as expiration of patents, drying pipelines and major slowdowns in economies may hamper the market growth.

The rising public and private investment in hospitals is expected to create significant opportunities for the market. By end users, the market is segmented into various subtypes, viz. hospitals, eye clinics, diagnostic centers, and patients' ophthalmic drugs. The hospitals segment is estimated to grow with the highest during 2016-2022, whereas the eye clinic segment is expected to have the fastest growth. On the basis of revenue, hospital care market has the highest market share, and homecare market is expected to have the fastest growth rate. On the basis of geography, the market is segmented into North America, Europe, Asia-Pacific and rest of the world. At present, North America has the largest market share, followed by Europe and Asia Pacific. The North American market is driven by high awareness, greater availability of drugs due to presence of major players, and an elaborate regulatory framework. However, Asia Pacific market is expected to have the highest CAGR during the forecast period and it is driven by the strong markets of China and India.

Table of Contents

1. INTRODUCTION

  • 1.1. EXECUTIVE SUMMARY
  • 1.2. ESTIMATION METHODOLOGY

2. MARKET OVERVIEW

  • 2.1. MARKET DEFINITION AND SCOPE
  • 2.2. KEY FINDINGS
  • 2.3. PARAMETRIC ANALYSIS
  • 2.4. KEY MARKET INSIGHTS
    • 2.4.1. TOP EMERGING COUNTRIES
    • 2.4.2. TOP REVENUE GENERATING SEGMENTS
    • 2.4.3. TOP GROWING MARKETS AND EMERGING TRENDS
  • 2.5. COMPETITIVE LANDSCAPE
    • 2.5.1. MARKET SHARE ANALYSIS
    • 2.5.2. TOP WINNING STRATEGIES
    • 2.5.3. CASE STUDIES: TOP COMPETITIVE MOVES
  • 2.6. PORTER'S FIVE FORCE MODEL
    • 2.6.1. THREAT OF NEW ENTRANTS
    • 2.6.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
    • 2.6.3. BARGAINING POWER OF BUYER
    • 2.6.4. BARGAINING POWER OF SUPPLIER
    • 2.6.5. INTENSITY OF COMPETITIVE RIVALRY
  • 2.7. KEY BUYING CRITERIA
  • 2.8. STRATEGIC RECOMMENDATION
  • 2.9. STRATEGIC CONCLUSIONS

3. MARKET DETERMINANTS

  • 3.1. MARKET DRIVERS
    • 3.1.1. GLOBAL RISE IN HEALTHCARE EXPENDITURE
    • 3.1.2. INCREASING ELDERLY POPULATION
    • 3.1.3. TECHNOLOGICAL ADVANCEMENT
    • 3.1.4. INNOVATION LEADING TO DEVELOPMENT OF NEW OPHTHALMOLOGY DRUGS
    • 3.1.5. TECHNOLOGICAL ADVANCEMENT
    • 3.1.6. RISING PREVALENCE RATE OF EYE DISEASES
  • 3.2. MARKET RESTRAINTS
    • 3.2.1. DRYING PIPELINE PROJECTS
    • 3.2.2. EXPIRY OF PATENTS
  • 3.3. MARKET OPPORTUNITIES
    • 3.3.1. EMERGING MARKETS
    • 3.3.2. INCREASED AWARENESS
  • 3.4. PARENT MARKET
  • 3.5. COMPETITORS MARKET
  • 3.6. ALTERNATIVE MARKET

4. MARKET SEGMENTATION

  • 4.1. GLOBAL OPHTHALMIC DRUGS MARKET BY THERAPEUTICS 2014-2022 ($ MILLION)
    • 4.1.1. GLOBAL GLAUCOMA OPHTHALMIC DRUGS MARKET 2014-2022 ($ MILLION)
    • 4.1.2. GLOBAL DRY EYE OPHTHALMIC DRUGS MARKET 2014-2022 ($ MILLION)
    • 4.1.3. GLOBAL RETINAL DISORDER OPHTHALMIC DRUGS MARKET 2014-2022 ($ MILLION)
    • 4.1.4. GLOBAL ALLERGIC CONJUNCTIVITIS OPHTHALMIC DRUGS MARKET 2014-2022 ($ MILLION)
  • 4.2. GLOBAL OPHTHALMIC DRUGS MARKET BY TYPE 2014-2022 ($ MILLION)
    • 4.2.1. GLOBAL PRESCRIPTION OPHTHALMIC DRUGS MARKET 2014-2022 ($ MILLION)
    • 4.2.2. GLOBAL OTC (OVER THE COUNTER DRUGS) OPHTHALMIC DRUGS MARKET 2014-2022 ($ MILLION)
  • 4.3. GLOBAL OPHTHALMIC DRUGS MARKET BY END USER 2014-2022 ($ MILLION)
    • 4.3.1. GLOBAL HOSPITALS OPHTHALMIC DRUGS MARKET 2014-2022 ($ MILLION)
    • 4.3.2. GLOBAL DIAGNOSTIC CENTERS OPHTHALMIC DRUGS MARKET 2014-2022 ($ MILLION)
    • 4.3.3. GLOBAL EYE CLINICS OPHTHALMIC DRUGS MARKET 2014-2022 ($ MILLION)
    • 4.3.4. GLOBAL PATIENTS OPHTHALMIC DRUGS MARKET 2014-2022 ($ MILLION)

5. GEOGRAPHICAL ANALYSIS

  • 5.1. NORTH AMERICA OPHTHALMIC DRUGS MARKET 2014-2022 ($ MILLION)
    • 5.1.1. UNITED STATES (U.S.) OPHTHALMIC DRUGS MARKET 2014-2022 ($ MILLION)
    • 5.1.2. CANADA OPHTHALMIC DRUGS MARKET 2014-2022 ($ MILLION)
  • 5.2. EUROPE OPHTHALMIC DRUGS MARKET 2014-2022 ($ MILLION)
    • 5.2.1. UNITED KINGDOM (UK) OPHTHALMIC DRUGS MARKET 2014-2022 ($ MILLION)
    • 5.2.2. FRANCE OPHTHALMIC DRUGS MARKET 2014-2022 ($ MILLION)
    • 5.2.3. GERMANY OPHTHALMIC DRUGS MARKET 2014-2022 ($ MILLION)
    • 5.2.4. SPAIN OPHTHALMIC DRUGS MARKET 2014-2022 ($ MILLION)
    • 5.2.5. ITALY OPHTHALMIC DRUGS MARKET 2014-2022 ($ MILLION)
    • 5.2.6. ROE OPHTHALMIC DRUGS MARKET 2014-2022 ($ MILLION)
  • 5.3. ASIA PACIFIC OPHTHALMIC DRUGS MARKET 2014-2022 ($ MILLION)
    • 5.3.1. INDIA OPHTHALMIC DRUGS MARKET 2014-2022 ($ MILLION)
    • 5.3.2. CHINA OPHTHALMIC DRUGS MARKET 2014-2022 ($ MILLION)
    • 5.3.3. JAPAN OPHTHALMIC DRUGS MARKET 2014-2022 ($ MILLION)
    • 5.3.4. ROAPAC OPHTHALMIC DRUGS MARKET 2014-2022 ($ MILLION)
  • 5.4. REST OF THE WORLD OPHTHALMIC DRUGS MARKET 2014-2022 ($ MILLION)
    • 5.4.1. LATIN AMERICA OPHTHALMIC DRUGS MARKET 2014-2022 ($ MILLION)
    • 5.4.2. MENA OPHTHALMIC DRUGS MARKET 2014-2022 ($ MILLION)
    • 5.4.3. AFRICA OPHTHALMIC DRUGS MARKET 2014-2022 ($ MILLION)

6. COMPANY PROFILES

  • 1. ABBOT LABORATORIES
  • 2. AKORN
  • 3. ALLERGAN INC.
  • 4. BAYER
  • 5. CIPLA PHARMACEUTICALS
  • 6. EYE GATE PHARMACEUTICALS
  • 7. EYEMED
  • 8. GLAXOSMITHKLINE
  • 9. JOHNSON AND JOHNSON
  • 10. LPATH
  • 11. MERCK & CO.
  • 12. NOVAGALI PHARMA S.A.
  • 13. NOVARTIS AG
  • 14. PFIZER INC.
  • 15. REGENERON
  • 16. ROCHE HOLDING AG
  • 17. SANTEN PHARMACEUTICAL CO. LTD.
  • 18. SENJU
  • 19. SUN PHARMACEUTICALS
  • 20. VALEANT

LIST OF TABLES

  • 1. GLOBAL OPHTHALMIC DRUGS MARKET BY TYPE 2014-2022 ($ MILLION)
  • 2. GLOBAL PRESCRIPTION OPHTHALMIC DRUGS MARKET 2014-2022 ($ MILLION)
  • 3. GLOBAL OTC (OVER THE COUNTER DRUGS) OPHTHALMIC DRUGS MARKET 2014-2022 ($ MILLION)
  • 4. GLOBAL OPHTHALMIC DRUGS MARKET BY THERAPEUTICS 2014-2022 ($ MILLION)
  • 5. GLOBAL GLAUCOMA OPHTHALMIC DRUGS MARKET 2014-2022 ($ MILLION)
  • 6. GLOBAL RETINAL DISORDER OPHTHALMIC DRUGS MARKET 2014-2022 ($ MILLION)
  • 7. GLOBAL DRY EYE OPHTHALMIC DRUGS MARKET 2014-2022 ($ MILLION)
  • 8. GLOBAL ALLERGIC CONJUNCTIVITIS OPHTHALMIC DRUGS MARKET 2014-2022 ($ MILLION)
  • 9. GLOBAL OPHTHALMIC DRUGS MARKET BY END USER 2014-2022 ($ MILLION)
  • 10. GLOBAL HOSPITALS OPHTHALMIC DRUGS MARKET 2014-2022 ($ MILLION)
  • 11. GLOBAL EYE CLINICS OPHTHALMIC DRUGS MARKET 2014-2022 ($ MILLION)
  • 12. GLOBAL DIAGNOSTIC CENTERS OPHTHALMIC DRUGS MARKET 2014-2022 ($ MILLION)
  • 13. GLOBAL PATIENTS OPHTHALMIC DRUGS MARKET 2014-2022 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL OPHTHALMIC DRUGS INDUSTRY MARKET SHARE 2014-2022 ($ MILLION)
  • 2. MARKET SHARE BY REGION
  • 3. UNITED STATES MARKET ESTIMATES AND FORECAST 2014-2022 ($ MILLION)
  • 4. CANADA MARKET ESTIMATES AND FORECAST 2014-2022 ($ MILLION)
  • 5. MEXICO MARKET ESTIMATES AND FORECAST 2014-2022 ($ MILLION)
  • 6. UK MARKET ESTIMATES AND FORECAST 2014-2022 ($ MILLION)
  • 7. FRANCE MARKET ESTIMATES AND FORECAST 2014-2022 ($ MILLION)
  • 8. GERMANY MARKET ESTIMATES AND FORECAST 2014-2022 ($ MILLION)
  • 9. APAC MARKET ESTIMATES AND FORECAST 2014-2022 ($ MILLION)
  • 10. CHINA MARKET ESTIMATES AND FORECAST 2014-2022 ($ MILLION)
  • 11. INDIA MARKET ESTIMATES AND FORECAST 2014-2022 ($ MILLION)
  • 12. MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2014-2022 ($ MILLION)
  • 13. CENTRAL & SOUTH AMERICA MARKET ESTIMATES AND FORECAST 2014-2022 ($ MILLION)
  • 14. BRAZIL MARKET ESTIMATES AND FORECAST 2014-2022 ($ MILLION)
Back to Top